Skip to main content
Fig. 4 | Nutrition Journal

Fig. 4

From: Placebo-controlled randomized clinical trial of fish oil’s impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus

Fig. 4

Disease Activity Assessments. Physician’s Global Assessment a Dot plot of score changes (p = 0.015), a higher score is indicative of worse overall disease activity; therefore a negative delta denotes improvement. SELENA-SLEDAI b Dot plot of change scores (p = 0.42) and c Renal component delta for LN patients only, Placebo N = 10 and Fish Oil N = 14, (p = 0.35), a higher score is indicative of higher disease activity; therefore a negative delta denotes improvement. For all graphs, center bar represents median and upper and lower bars are the 25th and 75th percentiles. Data were analyzed with Mann–Whitney U tests

Back to article page

Nutrition Journal

ISSN: 1475-2891

Contact us